Loading clinical trials...
Loading clinical trials...
A Phase I Study of ARQ 197 in Combination With IV Topotecan in Advanced Solid Tumors With an Expansion Cohort in Small Cell Lung Cancer
Conditions
Interventions
Laboratory Biomarker Analysis
Pegfilgrastim
+3 more
Locations
7
United States
City of Hope Comprehensive Cancer Center
Duarte, California, United States
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
City of Hope South Pasadena
South Pasadena, California, United States
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, United States
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, United States
Start Date
July 24, 2012
Primary Completion Date
March 29, 2018
Completion Date
March 29, 2018
Last Updated
April 3, 2018
NCT01217411
NCT02054741
NCT02822365
NCT00499135
NCT00608361
NCT01218620
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions